Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer’s disease
- 4 April 2006
- journal article
- research article
- Published by Springer Nature in Amino Acids
- Vol. 31 (4) , 449-456
- https://doi.org/10.1007/s00726-005-0272-z
Abstract
Premature aging and neuropathological features of Alzheimer’s disease (AD) are commonly observed in Down syndrome (DS). Based on previous findings in a DS mouse model, the function of signaling pathways associated with adenylyl cyclase (AC) and phospholipase C (PLC) was assessed in cerebral cortex and cerebellum of age-matched adults with DS, AD, and controls. Basal production of cAMP was reduced in DS but not in AD cortex, and in both, DS and AD cerebellum. Responses to GTPγS, noradrenaline, SKF 38393 and forskolin were more depressed in DS than in AD cortex and cerebellum. Although no differences in PLC activity among control, DS and AD cortex were observed under basal and GTPγS- or Ca-stimulated conditions, the response of DS cortex to serotonergic and cholinergic stimulation was depressed, and that of AD was only impaired at cholinergic stimulation. No differences were documented in cerebellum. Our results demonstrate that PLC and AC were severely disturbed in the aged DS and AD brains, but the alterations in DS were more severe, and differed to some extent from those observed in AD.Keywords
This publication has 34 references indexed in Scilit:
- Pitfalls And Hopes in Down Syndrome Therapeutic Approaches: In the Search for Evidence-Based TreatmentsBehavior Genetics, 2006
- Down syndrome, Alzheimer's disease and seizuresBrain & Development, 2005
- Reduced phospholipase C‐β activity and isoform expression in the cerebellum of TS65DN mouse: A model of down syndromeJournal of Neuroscience Research, 2001
- 10 Years ofGenomics,Chromosome 21, and Down SyndromeGenomics, 1998
- Ca2+/CaM-sensitive adenylyl cyclase activity is decreased in the Alzheimer's brain: Possible relation to type I adenylyl cyclaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brainNeurobiology of Aging, 1997
- Impaired cyclic AMP production in the hippocampus of a Down syndrome murine modelDevelopmental Brain Research, 1996
- Cholinergic and serotonergic stimulation of phosphoinositide hydrolysis is decreased in Alzheimer's diseaseLife Sciences, 1994
- Dose-related effects of prenatal 5-methoxytryptamine (5-MT) on development of serotonin terminal density and behaviorDevelopmental Brain Research, 1991
- Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementiaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984